- NEUTRAL
Quarterly Revenue Ramdevbaba Solvent Mar-2026 Quarterly Revenue is Rs 0 Cr which is growth of 0% YoY.
- NEUTRAL
Quarterly Net Profit Ramdevbaba Solvent Mar-2026 Quarterly Net Profit is Rs 0 Cr which is growth of 0% YoY.
80.00-1.00(-1.23%)
800
NSE Volume
NSE 05 Oct, 2026 3:16 PM (IST)
Ramdevbaba Solvent quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Ramdevbaba Solvent quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph |
|---|---|
Operating Exp. | |
Operating Profit | |
Operating Profit Margin % | |
Depr. | |
Interest | |
Profit Before Tax | |
Tax | |
Net Profit | |
EPS Adj. latest | |
Net profit TTM | |
Basic EPS TTM |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Ramdevbaba Solvent competitor comparison and performance snapshot within industry
Ramdevbaba Solvent annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Annual Revenue Ramdevbaba Solvent Mar-2026 Annual Revenue is Rs 830 Cr which is growth of -11.3% YoY.
- NEGATIVE
Annual Net Profit Ramdevbaba Solvent Mar-2026 Annual Net Profit is Rs 14 Cr which is growth of -3.7% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5.5% | 14.3% | 829.9 | 935.6 | 693 | 706.4 | 584.7 | 425.7 | 349.7 | 199.7 | 182.6 | 188.1 | 133.4 | ||
Operating Exp. Ann. | 5.4% | 14.2% | 795.7 | 902.6 | 661.3 | 679.2 | 565.8 | 410.5 | 336.9 | 190.2 | 174.7 | 181.4 | 128.1 | |
Operating Profit Ann. | 11.4% | 13.7% | 25.6 | 25.8 | 25.1 | 18.5 | 17.1 | 13.5 | 12 | 9.1 | 7.4 | 5.9 | 5.1 | |
OPM Ann. % | 5.5% | -0.5% | 3.08% | 2.76% | 3.62% | 2.62% | 2.92% | 3.16% | 3.43% | 4.55% | 4.04% | 3.12% | 3.79% | |
5.7% | 14.1% | 810.4 | 915.5 | 675.3 | 687.1 | 576.2 | 418.5 | 343.4 | 196 | 177.8 | 185.1 | 132.4 | ||
EBITDA Ann. | 7.9% | 17.6% | 34.2 | 33 | 31.7 | 27.2 | 18.9 | 15.2 | 12.8 | 9.5 | 8 | 6.7 | 5.3 | |
EBITDA Ann. margin % | 2.4% | 2.9% | 4.12% | 3.53% | 4.57% | 3.84% | 3.23% | 3.57% | 3.65% | 4.74% | 4.36% | 3.54% | 3.93% | |
Interest Ann. | 18.1% | 19.9% | 9.4 | 8 | 9.7 | 5.7 | 5.2 | 3.8 | 3.5 | 2.7 | 1.6 | 2 | 2.4 | |
Depr. | 34.1% | 4.3% | 5.3 | 4.8 | 4.3 | 2.2 | 5.2 | 4.3 | 3 | 3.1 | 1.5 | 1.7 | 1.9 | |
PBT Ann. | 0.3% | 22.1% | 19.5 | 20.1 | 17.7 | 19.3 | 8.5 | 7.2 | 6.3 | 3.7 | 4.8 | 3 | 1 | |
Tax Ann. | 2.8% | 29% | 5 | 5.1 | 4.7 | 4.6 | 1.9 | 1.4 | 1.2 | 1.6 | 1 | 0.3 | ||
-0.5% | 20.1% | 14.5 | 15 | 13 | 14.7 | 6.7 | 5.8 | 5.1 | 3.7 | 3.3 | 2 | 0.7 | ||
Net Profit Ann. | -0.5% | 20.1% | 14.5 | 15 | 13 | 14.7 | 6.7 | 5.8 | 5.1 | 3.7 | 3.3 | 2 | 0.7 | |
NPM Ann. % | -5.7% | 5.4% | 1.76% | 1.61% | 1.89% | 2.10% | 1.14% | 1.35% | 1.45% | 1.86% | 1.78% | 1.07% | 0.52% | |
EPS Adj. latest Ann. | -0.5% | 20.1% | 6 | 6.3 | 5.4 | 6.1 | 2.8 | 2.4 | 2.1 | 1.6 | 1.4 | 0.8 | 0.3 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
-11.3%
2Y CAGR
9.4%
3Y CAGR
5.5%
5Y CAGR
14.3%
7Y CAGR
22.6%
10Y CAGR
20.1%
Total Revenue Annual is falling faster than historical averages.
Net Profit Ann.
1Y CHG
-3.3%
2Y CAGR
5.6%
3Y CAGR
-0.5%
5Y CAGR
20.1%
7Y CAGR
21.5%
10Y CAGR
35.4%
Net Profit Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
-11.8%
2Y CAGR
9.7%
3Y CAGR
5.4%
5Y CAGR
14.2%
7Y CAGR
22.7%
10Y CAGR
20%
Operating Expenses Annual Cr is falling faster than historical averages.
Ramdevbaba Solvent balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Ramdevbaba Solvent Mar-2025 Total Shareholders Fund is Rs 166 Cr which is growth of 9.6% YoY.
- POSITIVE
Total Assets Ramdevbaba Solvent Mar-2025 Total Assets is Rs 325 Cr which is growth of 12.5% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51.4% | 41.8% | 166 | 151.5 | 72.8 | 47.8 | 35.7 | 29 | 23.3 | 19 | 15.2 | 10 | 8 | ||
Minority Interest Liability Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
-16.9% | -2.7% | 26.2 | 33.2 | 40.7 | 45.6 | 42.8 | 30 | 23.8 | 14.2 | 4.9 | 4 | 12.2 | ||
10.9% | 26.9% | 132.7 | 104.1 | 115.7 | 97.2 | 50.6 | 40.4 | 32.8 | 30.2 | 24.5 | 22.7 | 18.1 | ||
Total Capital Plus Liabilities Ann. | 19.5% | 26.7% | 324.9 | 288.9 | 229.2 | 190.6 | 129.1 | 99.4 | 79.9 | 63.3 | 44.7 | 36.7 | 38.3 | |
9.4% | 24.5% | 117.4 | 109.9 | 97 | 89.6 | 52.3 | 39.3 | 30.2 | 30.2 | 22.8 | 13.5 | 14.4 | ||
21.7% | 32.7% | 165.2 | 159.3 | 109.8 | 91.7 | 53.3 | 40.2 | 31.1 | 31.1 | 23.5 | 14 | 14.8 | ||
17.3% | 22% | 159.8 | 129.5 | 119.4 | 98.9 | 75.8 | 59.2 | 48.8 | 32.3 | 21.2 | 22.7 | 23.5 | ||
Total Assets Ann. | 19.5% | 26.7% | 324.9 | 288.9 | 229.2 | 190.6 | 129.1 | 99.4 | 79.9 | 63.3 | 44.7 | 36.7 | 38.3 | |
Contingent Liabilities plus Commitments Ann. | - | - | - | 3 | 8.6 | 2.5 | 2.5 | |||||||
Bonus Equity Share Capital Ann. | - | - | - | |||||||||||
Non Current Investments Unquoted Book Value Ann. | - | - | - | 0.1 | 0.2 | |||||||||
Current Investments Unquoted Book Value Ann. | - | - | - |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
12.5%
2Y CAGR
19.1%
3Y CAGR
19.5%
5Y CAGR
26.7%
7Y CAGR
26.3%
10Y CAGR
23.8%
Total Assets Annual growth is lower than historical averages.
Total Current Liabilities Ann.
1Y CHG
27.5%
2Y CAGR
7.1%
3Y CAGR
10.9%
5Y CAGR
26.9%
7Y CAGR
23.5%
10Y CAGR
22%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
9.6%
2Y CAGR
51%
3Y CAGR
51.4%
5Y CAGR
41.8%
7Y CAGR
36.3%
10Y CAGR
35.4%
Total ShareHolders Funds Annual growth is lower than historical averages.
Ramdevbaba Solvent ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share Ramdevbaba Solvent Mar-2025 Book Value Per Share is 73 Rs which is growth of 9.6% YoY.
- POSITIVE
ROE Ramdevbaba Solvent Mar-2025 ROE is 9% which is growth of 1.2% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BVSH Ann. | -58.9% | -35.1% | 72.6 | 66.3 | 44.9 | 1,042.7 | 777.7 | 632.4 | 506.8 | 413.2 | 332.2 | 278.5 | 222.3 | |
RoA Ann. % | -16.7% | -5.2% | 4.45% | 5.20% | 5.68% | 7.70% | 5.16% | 5.80% | 6.36% | 5.86% | 7.27% | 5.49% | 1.82% | |
ROE Ann. % | -34.3% | -15.2% | 8.72% | 9.92% | 17.91% | 30.70% | 18.67% | 19.87% | 21.86% | 19.60% | 21.31% | 20.17% | 8.76% | |
ROCE Ann. % | -17.4% | -4.2% | 15.02% | 15.24% | 24.13% | 26.68% | 17.45% | 18.57% | 20.76% | 19.36% | 31.86% | 35.61% | 16.79% | |
Total Debt to Total Equity Ann. | -34.1% | -16.7% | 0.6 | 0.6 | 1.5 | 2.1 | 1.8 | 1.5 | 1.7 | 1.5 | 1.3 | 1.8 | 2.9 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
-12.1%
2Y CAGR
-30.2%
3Y CAGR
-34.3%
5Y CAGR
-15.2%
7Y CAGR
-10.9%
10Y CAGR
0%
ROE Annual % is falling faster than historical averages.
RoA Ann. %
1Y CHG
-14.4%
2Y CAGR
-11.5%
3Y CAGR
-16.7%
5Y CAGR
-5.2%
7Y CAGR
-3.9%
10Y CAGR
9.4%
RoA Annual % is falling faster than historical averages.
Current Ratio Ann.
2Y CAGR
9.5%
3Y CAGR
6.3%
5Y CAGR
-4.4%
7Y CAGR
1.3%
10Y CAGR
-0.8%
Current Ratio Annual is falling faster than historical averages.
Ramdevbaba Solvent cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Cash From Operating Activity Ramdevbaba Solvent Mar-2026 Cash From Operating Activity is Rs 7 Cr which is growth of 159.9% YoY.
- NEGATIVE
Net Cash Flow Ramdevbaba Solvent Mar-2026 Net Cash Flow is Rs -3 Cr which is growth of -197.5% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-12.9% | -8.8% | 7.2 | -12 | 5 | 10.9 | 2.7 | 11.4 | -3.2 | 3.5 | 9.5 | 6.9 | 0.1 | ||
Cash from Investing Act. Ann. | - | - | -12.7 | -24 | -19 | -39.3 | -18.3 | -13.3 | 3 | -10.6 | -11 | -0.7 | -0.7 | |
Cash from Financing Act. Ann. | -55.6% | 0.8% | 2.5 | 39.1 | 13.9 | 28.5 | 15.2 | 2.4 | 6 | 7.1 | 1.4 | -6.5 | 0.8 | |
- | - | -3 | 3.1 | -0.2 | 0.2 | -0.4 | 0.5 | 5.7 | -0.1 | -0.2 | -0.4 | 0.2 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Operating Act. Ann.
2Y CAGR
20%
3Y CAGR
-12.9%
5Y CAGR
-8.8%
7Y CAGR
10.9%
10Y CAGR
53.4%
Cash from Operating Activity Annual growth is higher than historical averages.
Cash from Financing Act. Ann.
1Y CHG
-93.6%
2Y CAGR
-57.6%
3Y CAGR
-55.6%
5Y CAGR
0.8%
7Y CAGR
-13.9%
10Y CAGR
12.1%
Cash from Financing Annual Activity is falling faster than historical averages.
